Dougherty & Company

In a report published earlier today, Dougherty & Company LLC reiterated its Buy rating and $68.00 price target for Raven Industries (NASDAQ: RAVN). Dougherty & Company said in its report “We think investors should be pleased with the strong results and unchanged long-term 10%+ growth...

Listed below are today's Top Upgrades at Benzinga: Dougherty & Company Upgrades Caribou Coffee (NASDAQ: CBOU) to Buy: Dougherty & Company said in its report “CBOU has developed a strong track record on its turnaround initiatives in recent years. Solid retail execution founded on expanding...

Are investors right to panic over Caribou Coffee's (NASDAQ: CBOU) recent Keurig cup downfall? Opinions regarding the recent struggle are mixed, but there is no doubt that CBOU is seeing increased competition in the K-cup category from Starbucks (NASDAQ: SBUX), Dunkin Brands (NASDAQ: DNKN) and Green...

In a report published earlier today, Dougherty & Company LLC upgraded its rating for Caribou Coffee Company (NASDAQ: CBOU) from Neutral to Buy, and reiterated its $15.00 price target. Dougherty & Company said in its report “CBOU has developed a strong track record on its turnaround...

Dougherty & Company increases its price target from $12.50 to $15,50 on Buy-rated IntegraMed America (NASDAQ: INMD) following solid results for Q1. Dougherty & Company comments, "INMD reported 1Q adjusted EPS of $0.11 vs. $0.08 (+37.5%) which exceeded our $0.10 forecast by $0.01. Revenue...

According to a research report published this morning, Dougherty & Company has increased DTS' (NASDAQ: DTSI) PT from $30 to $34. Dougherty & Company commented in the report, "DTS posted Q1 non-GAAP results of $26.9M/$0.37, exceeding our $25.2M/$0.35 and the consensus of $25.5M/$0.35....

Listed below are today's Top Downgrades at Benzinga: Stifel Nicolaus Downgrades BioMed Realty (NYSE: BMR) to Hold: Stifel Nicolaus comments, "We are downgrading BioMed Realty to a Hold rating as we think: 1) BMR is fully valued with an Implied NOI/Cash Flow/CF less G&A cap rates of 6.4%/5.5%/...

According to a research report published this morning, Dougherty & Company has increased Trimble Navigation's (NASDAQ: TRMB) PT from $57 to $62. In the report, Dougherty & Company mentioned, "Trimble continues to prove that its location technology and industry-specific software is a...

According to a research report published this morning, Dougherty & Company has downgraded Green Mountain Coffee Roasters (NASDAQ: GMCR) from Buy to Neutral, and lowered PT from $65 to $35. Dougherty & Company said, "The March quarter demonstrated major deterioration in fundamental...

Listed below are today's Top Downgrades at Benzinga: Dougherty & Company Downgrades Bio-Rad Laboratories (NYSE: BIO) to Neutral: Dougherty & Company mentioned, "Our NEUTRAL rated stance is predicated on the following: 1) A slower-than-expected start to the new year on the sales front –...